Efficient engraftment and viral transduction of human hepatocytes in an FRG rat liver humanization model

Abstract Humanized liver rodent models, in which the host liver parenchyma is repopulated by human hepatocytes, have been increasingly used for drug development and disease research. Unlike the leading humanized liver mouse model in which Fumarylacetoacetate Hydrolase (Fah), Recombination Activating...

Full description

Bibliographic Details
Main Authors: Marisa Carbonaro, Jeffrey Lee, Evangelos Pefanis, Mathieu Desclaux, Kehui Wang, Alexander Pennington, Hui Huang, Alejo Mujica, Jose Rojas, Roxanne Ally, Daniel Kennedy, Michael Brown, Vitaliy Rogulin, Sven Moller-Tank, Leah Sabin, Brian Zambrowicz, Gavin Thurston, Zhe Li
Format: Article
Language:English
Published: Nature Portfolio 2022-08-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-18119-6
_version_ 1817999218274467840
author Marisa Carbonaro
Jeffrey Lee
Evangelos Pefanis
Mathieu Desclaux
Kehui Wang
Alexander Pennington
Hui Huang
Alejo Mujica
Jose Rojas
Roxanne Ally
Daniel Kennedy
Michael Brown
Vitaliy Rogulin
Sven Moller-Tank
Leah Sabin
Brian Zambrowicz
Gavin Thurston
Zhe Li
author_facet Marisa Carbonaro
Jeffrey Lee
Evangelos Pefanis
Mathieu Desclaux
Kehui Wang
Alexander Pennington
Hui Huang
Alejo Mujica
Jose Rojas
Roxanne Ally
Daniel Kennedy
Michael Brown
Vitaliy Rogulin
Sven Moller-Tank
Leah Sabin
Brian Zambrowicz
Gavin Thurston
Zhe Li
author_sort Marisa Carbonaro
collection DOAJ
description Abstract Humanized liver rodent models, in which the host liver parenchyma is repopulated by human hepatocytes, have been increasingly used for drug development and disease research. Unlike the leading humanized liver mouse model in which Fumarylacetoacetate Hydrolase (Fah), Recombination Activating Gene (Rag)-2 and Interleukin-2 Receptor Gamma (Il2rg) genes were inactivated simultaneously, generation of similar recipient rats has been challenging. Here, using Velocigene and 1-cell-embryo-targeting technologies, we generated a rat model deficient in Fah, Rag1/2 and Il2rg genes, similar to humanized liver mice. These rats were efficiently engrafted with Fah-expressing hepatocytes from rat, mouse and human. Humanized liver rats expressed human albumin and complement proteins in serum and showed a normal liver zonation pattern. Further, approaches were developed for gene delivery through viral transduction of human hepatocytes either in vivo, or in vitro prior to engraftment, providing a novel platform to study liver disease and hepatocyte-targeted therapies.
first_indexed 2024-04-14T03:05:29Z
format Article
id doaj.art-f36f9f2973d74161ab4380d6be2edfb7
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-14T03:05:29Z
publishDate 2022-08-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-f36f9f2973d74161ab4380d6be2edfb72022-12-22T02:15:45ZengNature PortfolioScientific Reports2045-23222022-08-0112111110.1038/s41598-022-18119-6Efficient engraftment and viral transduction of human hepatocytes in an FRG rat liver humanization modelMarisa Carbonaro0Jeffrey Lee1Evangelos Pefanis2Mathieu Desclaux3Kehui Wang4Alexander Pennington5Hui Huang6Alejo Mujica7Jose Rojas8Roxanne Ally9Daniel Kennedy10Michael Brown11Vitaliy Rogulin12Sven Moller-Tank13Leah Sabin14Brian Zambrowicz15Gavin Thurston16Zhe Li17Regeneron Pharmaceuticals, Inc.Regeneron Pharmaceuticals, Inc.Regeneron Pharmaceuticals, Inc.Regeneron Pharmaceuticals, Inc.Regeneron Pharmaceuticals, Inc.Regeneron Pharmaceuticals, Inc.Regeneron Pharmaceuticals, Inc.Regeneron Pharmaceuticals, Inc.Regeneron Pharmaceuticals, Inc.Regeneron Pharmaceuticals, Inc.Regeneron Pharmaceuticals, Inc.Regeneron Pharmaceuticals, Inc.Regeneron Pharmaceuticals, Inc.Regeneron Pharmaceuticals, Inc.Regeneron Pharmaceuticals, Inc.Regeneron Pharmaceuticals, Inc.Regeneron Pharmaceuticals, Inc.Regeneron Pharmaceuticals, Inc.Abstract Humanized liver rodent models, in which the host liver parenchyma is repopulated by human hepatocytes, have been increasingly used for drug development and disease research. Unlike the leading humanized liver mouse model in which Fumarylacetoacetate Hydrolase (Fah), Recombination Activating Gene (Rag)-2 and Interleukin-2 Receptor Gamma (Il2rg) genes were inactivated simultaneously, generation of similar recipient rats has been challenging. Here, using Velocigene and 1-cell-embryo-targeting technologies, we generated a rat model deficient in Fah, Rag1/2 and Il2rg genes, similar to humanized liver mice. These rats were efficiently engrafted with Fah-expressing hepatocytes from rat, mouse and human. Humanized liver rats expressed human albumin and complement proteins in serum and showed a normal liver zonation pattern. Further, approaches were developed for gene delivery through viral transduction of human hepatocytes either in vivo, or in vitro prior to engraftment, providing a novel platform to study liver disease and hepatocyte-targeted therapies.https://doi.org/10.1038/s41598-022-18119-6
spellingShingle Marisa Carbonaro
Jeffrey Lee
Evangelos Pefanis
Mathieu Desclaux
Kehui Wang
Alexander Pennington
Hui Huang
Alejo Mujica
Jose Rojas
Roxanne Ally
Daniel Kennedy
Michael Brown
Vitaliy Rogulin
Sven Moller-Tank
Leah Sabin
Brian Zambrowicz
Gavin Thurston
Zhe Li
Efficient engraftment and viral transduction of human hepatocytes in an FRG rat liver humanization model
Scientific Reports
title Efficient engraftment and viral transduction of human hepatocytes in an FRG rat liver humanization model
title_full Efficient engraftment and viral transduction of human hepatocytes in an FRG rat liver humanization model
title_fullStr Efficient engraftment and viral transduction of human hepatocytes in an FRG rat liver humanization model
title_full_unstemmed Efficient engraftment and viral transduction of human hepatocytes in an FRG rat liver humanization model
title_short Efficient engraftment and viral transduction of human hepatocytes in an FRG rat liver humanization model
title_sort efficient engraftment and viral transduction of human hepatocytes in an frg rat liver humanization model
url https://doi.org/10.1038/s41598-022-18119-6
work_keys_str_mv AT marisacarbonaro efficientengraftmentandviraltransductionofhumanhepatocytesinanfrgratliverhumanizationmodel
AT jeffreylee efficientengraftmentandviraltransductionofhumanhepatocytesinanfrgratliverhumanizationmodel
AT evangelospefanis efficientengraftmentandviraltransductionofhumanhepatocytesinanfrgratliverhumanizationmodel
AT mathieudesclaux efficientengraftmentandviraltransductionofhumanhepatocytesinanfrgratliverhumanizationmodel
AT kehuiwang efficientengraftmentandviraltransductionofhumanhepatocytesinanfrgratliverhumanizationmodel
AT alexanderpennington efficientengraftmentandviraltransductionofhumanhepatocytesinanfrgratliverhumanizationmodel
AT huihuang efficientengraftmentandviraltransductionofhumanhepatocytesinanfrgratliverhumanizationmodel
AT alejomujica efficientengraftmentandviraltransductionofhumanhepatocytesinanfrgratliverhumanizationmodel
AT joserojas efficientengraftmentandviraltransductionofhumanhepatocytesinanfrgratliverhumanizationmodel
AT roxanneally efficientengraftmentandviraltransductionofhumanhepatocytesinanfrgratliverhumanizationmodel
AT danielkennedy efficientengraftmentandviraltransductionofhumanhepatocytesinanfrgratliverhumanizationmodel
AT michaelbrown efficientengraftmentandviraltransductionofhumanhepatocytesinanfrgratliverhumanizationmodel
AT vitaliyrogulin efficientengraftmentandviraltransductionofhumanhepatocytesinanfrgratliverhumanizationmodel
AT svenmollertank efficientengraftmentandviraltransductionofhumanhepatocytesinanfrgratliverhumanizationmodel
AT leahsabin efficientengraftmentandviraltransductionofhumanhepatocytesinanfrgratliverhumanizationmodel
AT brianzambrowicz efficientengraftmentandviraltransductionofhumanhepatocytesinanfrgratliverhumanizationmodel
AT gavinthurston efficientengraftmentandviraltransductionofhumanhepatocytesinanfrgratliverhumanizationmodel
AT zheli efficientengraftmentandviraltransductionofhumanhepatocytesinanfrgratliverhumanizationmodel